Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Acquire Molecular Labeling Firms Quantum Dot and BioPixels

NEW YORK, Oct. 6 (GenomeWeb News) - Invitrogen will acquire Quantum Dot and the BioPixels business unit of BioCrystal, both molecular probe providers, the company said today. In addition, Invitrogen said it has has struck a deal with Georgia Tech Research to exclusively license nanocluster technology.

 

"These acquisitions, when combined with the license from Georgia Tech, provide Invitrogen with a significant intellectual property position and robust platform for product development based on advanced inorganic materials science for molecular detection," said Invitrogen's general manager of molecular probes, Augie Sick, in a company statement.

 

Invitrogen did not disclose the terms of the two acquisitions and the license agreement.

 

Quantum Dot offers biomolecular labeling and detection using its Quantum Dot semi-conductur nanocrystals, which emit bright light in a range of colors. BioPixels provides coatings and metal alloys for semi-conductor nanocrystals. Combining the two technologies will allow the creation of improved particles, according to Invitrogen.

 

The agreement with Georgia Tech gives the company access to nanoclusters that permit "true single molecule detection and representing another rapproach to the next generation of high sensitivity labeling and detection applications."

 

Further, Invitrogen said it has closed its acquisition of Biosource International. In July, the company announced its plan to purchase Biosource, a provider of proteins, antibodies, and other reagents, for $130 million in cash.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.